NEW YORK, April 28, 2017 /PRNewswire/ --
On Thursday, April 27, 2017, US markets sawbroad based gains with six out of nine sectors finishing the trading sessions in green. Major US indices were also bullish at the close of yesterday's session. The NASDAQ Composite ended the day at 6,048.94, up 0.39%; the Dow Jones Industrial Average
Yokneam, Israel-based Microbot Medical Inc.'s stock advanced 2.00%, to close the day at $5.11. The stock recorded a trading volume of 49,593 shares. The Company's shares are trading 10.77% and 32.56% below its 50-day and 200-day moving averages, respectively. Additionally, shares of the Company, which engages in the research, design, development, and commercialization of micro-robotics medical technologies, have a Relative Strength Index (RSI) of 39.67. Visit us today and download your complete report on MBOT for free at:
On Thursday, shares in Pleasanton, California headquartered The Cooper Cos. Inc. ended the session 0.31% lower at $199.37 with a total volume of 263,683 shares traded. Cooper Cos.' shares have advanced 0.16% in the last one month and 10.08% in the previous three months. Furthermore, the stock has gained 26.19% in the past one year. Shares of the Company, which operates as a medical device company worldwide, are trading at a PE ratio of 32.85. The stock is trading 1.17% above its 50-day moving average and 8.54% above its 200-day moving average. Moreover, the Company's shares have an RSI of 52.02. The complimentary research report on COO can be accessed at:
On Thursday, shares in Redwood City, California-based Dextera Surgical Inc. recorded a trading volume of 182,742 shares. The stock ended the day 3.37% lower at $0.80. Dextera Surgical's stock is trading below its 50-day and 200-day moving averages by 26.18% and 49.16%, respectively. Furthermore, shares of Dextera Surgical, which designs and manufactures proprietary stapling devices for minimally invasive surgical procedures in the US, Japan, Germany, and internationally, have an RSI of 29.70. Register for free on Stock-Callers.com and download the PDF research report on DXTR at:
Bedford, Massachusetts headquartered ConforMIS Inc.'s stock finished Thursday's session 0.35% lower at $5.62 with a total volume of 136,764 shares traded. ConforMIS' shares have gained 11.73% in the past one month. The Company's shares are trading above its 50-day moving average by 5.82%. Shares of ConforMIS, which develops, manufactures, and sells customized joint replacement implants, have an RSI of 63.84. Get free access to your research report on CFMS at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...
Antioxidants are artificial or natural components that help protect the human body from the damage ...
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...View All